Toxicity of Immune-Checkpoint Inhibitors in Hematological Malignancies

by Katarina Hradska, Roman Hajek, Roman Hajek, Tomas Jelinek, Tomas Jelinek
Published 2021-08-01

Update on PD-1/PD-L1 Inhibitors in Multiple Myeloma

by Tomas Jelinek, Tomas Jelinek, Tomas Jelinek, Tomas Jelinek, Bruno Paiva, Roman Hajek, Roman Hajek
Published 2018-11-01

Threats to Mutual Trust: Czech Local Politicians and Local Journalists in the Era of Professional Political Communication

by Roman Hájek, Jan Vávra, Tereza Svobodová
Published 2015-06-01

Czech Journalists’ Refreshed Sense of Ethics in the Midst of Media Ownership Turmoil

by Roman Hájek, Sandra Štefaniková, Filip Láb, Alice N. Tejkalová
Published 2015-12-01

The miR-29 family in hematological malignancies

by Barbora Fiserova, Lenka Kubiczkova, Lenka Sedlarikova, Roman Hajek, Sabina Sevcikova
Published 2015-06-01

Long Non-Coding RNAs in Multiple Myeloma

by Romana Butova, Petra Vychytilova-Faltejskova, Adela Souckova, Sabina Sevcikova, Roman Hajek
Published 2019-01-01

From open packing to negative wound pressure therapy. A critical overview of deep sternal wound infection treatment strategies after cardiac surgery

by Martin Simek, Adam Chudoba, Roman Hajek, Patrick Tobbia, Martin Molitor, Petr Nemec
Published 2018-11-01

Increased T regulatory cells are associated with adverse clinical features and predict progression in multiple myeloma.

by Karthick Raja Muthu Raja, Lucie Rihova, Lenka Zahradova, Maria Klincova, Miroslav Penka, Roman Hajek
Published 2012-01-01

Detection of tumor-specific marker for minimal residual disease in multiple myeloma patients

by Lenka Sedlarikova, Lena Kubiczkova, Fedor Kryukov, Jana Pelcova, Zdenek Adam, Ludek Pour, Roman Hajek, Sabina Sevcikova
Published 2015-12-01

Extramedullary relapse of multiple myeloma defined as the highest risk group based on deregulated gene expression data

by Sabina Sevcikova, Helena Paszekova, Lenka Besse, Lenka Sedlarikova, Veronika Kubaczkova, Martina Almasi, Ludek Pour, Roman Hajek
Published 2015-06-01

High levels of FLT3-ligand in bone marrow and peripheral blood of patients with advanced multiple myeloma.

by Normann Steiner, Roman Hajek, Sabina Sevcikova, Bojana Borjan, Karin Jöhrer, Georg Göbel, Gerold Untergasser, Eberhard Gunsilius
Published 2017-01-01

Plasmacytoid Dendritic Cells in Patients with MGUS and Multiple Myeloma

by Andrea Knight, Lucie Rihova, Romana Kralova, Miroslav Penka, Zdenek Adam, Ludek Pour, Martin Piskacek, Roman Hajek
Published 2021-08-01

The metabolomic plasma profile of myeloma patients is considerably different from healthy subjects and reveals potential new therapeutic targets.

by Normann Steiner, Udo Müller, Roman Hajek, Sabina Sevcikova, Bojana Borjan, Karin Jöhrer, Georg Göbel, Andreas Pircher, Eberhard Gunsilius
Published 2018-01-01

Functionally suppressive CD8 T regulatory cells are increased in patients with multiple myeloma: a cause for immune impairment.

by Karthick Raja Muthu Raja, Lenka Kubiczkova, Lucie Rihova, Martin Piskacek, Pavla Vsianska, Renata Hezova, Ludek Pour, Roman Hajek
Published 2012-01-01

A Bird’s-Eye View of Cell Sources for Cell-Based Therapies in Blood Cancers

by Benjamin Motais, Sandra Charvátová, Matouš Hrdinka, Michal Šimíček, Tomáš Jelínek, Tereza Ševčíková, Zdeněk Kořístek, Roman Hájek, Juli R. Bagó
Published 2020-05-01

Methodology of a Novel Risk Stratification Algorithm for Patients with Multiple Myeloma in the Relapsed Setting

by Walter Bouwmeester, Andrew Briggs, Ben van Hout, Roman Hájek, Sebastian Gonzalez-McQuire, Marco Campioni, Lucy DeCosta, Lucie Brozova
Published 2019-11-01

Intercellular Mitochondrial Transfer in the Tumor Microenvironment

by Hana Sahinbegovic, Tomas Jelinek, Matous Hrdinka, Juli R. Bago, Marcello Turi, Tereza Sevcikova, Amina Kurtovic-Kozaric, Roman Hajek, Michal Simicek
Published 2020-07-01

Single agent daratumumab in advanced multiple myeloma possesses significant efficacy even in an unselected "real-world" population

by Jiri Minarik, Ludek Pour, Vladimir Maisnar, Ivan Spicka, Alexandra Jungova, Tomas Jelinek, Lucie Brozova, Petra Krhovska, Vlastimil Scudla, Roman Hajek
Published 2019-09-01

Novel risk stratification algorithm for estimating the risk of death in patients with relapsed multiple myeloma: external validation in a retrospective chart review

by Roman Hájek, Sebastian Gonzalez-McQuire, Zsolt Szabo, Michel Delforge, Lucy DeCosta, Marc S Raab, Walter Bouwmeester, Marco Campioni, Andrew Briggs
Published 2020-07-01

Development of an Initial Conceptual Model of Multiple Myeloma to Support Clinical and Health Economics Decision Making

by Sebastian Gonzalez-McQuire, Meletios-Athanassios Dimopoulos, Katja Weisel, Walter Bouwmeester, Roman Hájek, Marco Campioni, Craig Bennison, Weiwei Xu, Krystallia Pantiri, Marja Hensen, Evangelos Terpos, Stefan Knop
Published 2019-01-01